Premium
What's new in the treatment of atopic dermatitis?
Author(s) -
Dattola Annunziata,
Bennardo Luigi,
Silvestri Martina,
Nisticò Steven Paul
Publication year - 2018
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.12787
Subject(s) - medicine , atopic dermatitis , dupilumab , dermatology , calcineurin , disease , tacrolimus , transplantation
Atopic dermatitis (AD) is a pruritic, chronic and inflammatory skin disease, with an usual onset in the pediatric age. Several drugs are used in the treatment of this skin disease. Drugs as steroid, calcineurin inhibitors, and moisturizing creams are widely used in the treatment of this disease but often patients are not satisfied with the obtained results. New drugs like dupilumab or crisaborole seem to be a promising option for moderate and severe forms of AD. This article analyzes the newest therapy available today for the treatment of AD.